Synthesis and biological activity of pyridinium-type acetylcholinesterase inhibitors

Journal of Pharmacy and Pharmacology

Volumn 55, Issue 10, 2003, Pages 1397-1404

  Alptüzün, Vildan ^a   Kapková, Petra ^b   Baumann, Knut ^b   Erciyas, Ercin ^a   Holzgrabe, Ulrike ^b  

^a EGE UNIVERSITY   (Turkey)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1 (3 HYDROXYPROPYL) 4 [[(PHTHALIMIDOMETHOXY]IMINO]METHYL]PYRIDINIUM DIBROMIDE; 1 (3 HYDROXYPROPYL) 4 [[[(2 CHLOROPHENYL)METHOXY]IMINO]METHYL]PYRIDINIUM BROMIDE; 1 (3 HYDROXYPROPYL) 4 [[[(2,6 DICHLOROPHENYL)METHOXY]IMINO]METHYL]PYRIDINIUM BROMIDE; 1 (3 PHENYLPROPYL) 4 [[(PHTHALIMIDOMETHOXY]IMINO]METHYL]PYRIDINIUM DIBROMIDE; 1 (3 PHENYLPROPYL) 4 [[[(2 CHLOROPHENYL)METHOXY]IMINO]METHYL]PYRIDINIUM BROMIDE; 1 (3 PHENYLPROPYL) 4 [[[(2,6 DICHLOROPHENYL)METHOXY]IMINO]METHYL]PYRIDINIUM BROMIDE; 1 [3 (4 METHOXYPHENYL)PROPYL] 4 [[(PHTHALIMIDOMETHOXY]IMINO]METHYL]PYRIDINIUM BROMIDE; 1 [3 (4 METHOXYPHENYL)PROPYL] 4 [[[(2 CHLOROPHENYL)METHOXY]IMINO]METHYL]PYRIDINIUM BROMIDE; 1 [3 (4 METHOXYPHENYL)PROPYL] 4 [[[(2,6 DICHLOROPHENYL)METHOXY]IMINO]METHYL]PYRIDINIUM BROMIDE; 1 [3 (PYRIDINIUM 1 YL)PROPYL] 4 [[(PHTHALIMIDOMETHOXY]IMINO]METHYL]PYRIDINIUM DIBROMIDE; 1 [3 (PYRIDINIUM 1 YL)PROPYL] 4 [[[(2 CHLOROPHENYL)METHOXY]IMINO]METHYL]PYRIDINIUM DIBROMIDE; 1 [3 (PYRIDINIUM 1 YL)PROPYL] 4 [[[(2,6 DICHLOROPHENYL)METHOXY]IMINO]METHYL]PYRIDINIUM DIBROMIDE; 1 ETHYL 4 [[(PHTHALIMIDOMETHOXY]IMINO]METHYL]PYRIDINIUM BROMIDE; 1 ETHYL 4 [[[(2 CHLOROPHENYL)METHOXY]IMINO]METHYL]PYRIDINIUM BROMIDE; 1 ETHYL 4 [[[(2,6 DICHLOROPHENYL)METHOXY]IMINO]METHYL]PYRIDINIUM BROMIDE; 1 PROPYL 4 [[(PHTHALIMIDOMETHOXY]IMINO]METHYL]PYRIDINIUM BROMIDE; 1 PROPYL 4 [[[(2 CHLOROPHENYL)METHOXY]IMINO]METHYL]PYRIDINIUM BROMIDE; 1 PROPYL 4 [[[(2,6 DICHLOROPHENYL)METHOXY]IMINO]METHYL]PYRIDINIUM BROMIDE; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; PYRIDINIUM DERIVATIVE; TACRINE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG SCREENING; DRUG STRUCTURE; ENZYME INHIBITION; IC 50; MOLECULE; SIDE EFFECT; STRUCTURE ACTIVITY RELATION;

ACETYLCHOLINESTERASE; BUTYRYLCHOLINESTERASE; CHOLINESTERASE INHIBITORS; PYRIDINIUM COMPOUNDS;

EID: 0142183252     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357021855     Document Type: Article

References (16)

1. Bejeuhr, G., Holzgrabe, U., Mohr, K., Sürig, U., Petersenn, A. (1992) Molecular modeling and synthesis of potent stabilizers of antagonist binding to M-cholinoceptors. Pharm. Pharmacol. Lett. 2: 100-103
2. Bevan, D. R., Donati, F., Kopman, A. F. (1992) Reversal of neuromuscular blockade. Anesthesiology 77: 785
3. Botero Cid, M. H., Holzgrabe, U., Kostenis, E., Mohr, K., Tränkle, C. (1994) Search for the pharmacophore of bispyridinium-type allosteric modulators of muscarinic receptors. J. Med. Chem. 37: 1439-1445
4. Bunyapaiboonsri, T., Ramström, O., Lohmann, S., Lehn, J.-M., Peng, L., Goeldner, M. (2001) Dynamic deconvolution of a pre-equilibrated dynamic combinatorial library of acetylcholinesterase inhibitors. Chembiochem. 2: 438-444
5. Carlier, P. R., Han, Y. F., Chow, E. S.-H., Li, C. P.-L., Wang, H., Lieu, T. X., Wong, H. S., Pang, Y.-P. (1999a) Evaluation of short-tether Bis-THA AChE inhibitors. A further test of the dual binding site hypothesis. Bioorg. Med. Chem. 7: 351-357
6. Carlier, P. R., Du, D.-M., Han, Y., Liu, J., Pang, Y.-P. (1999b) Potent, easily synthesized huperzine A-tacrine hybrid acetylcholinesterase inhibitors. Bioorg. Med. Chem. Lett. 9: 2335-2338
7. Critchlow, D. E., Fligner, M. A. (1991) On distribution-free multiple comparisons in the one-way analysis of variance. Commun. Statist.-Theory Meth. 20: 127-139
8. Ellman, G. L., Coutney, K. D., Andres, V., Featherstone, R. M. (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7: 88-95
9. Giacobini, E. (2000) Cholinesterases and Cholinesterase Inhibitors. Martin Dunitz, London, pp 27, 180
10. Guillou, C., Mary, A., Renko, D. Z., Gras, E., Thal, C. (2000) Potent acetylcholinesterase inhibitors: Design, synthesis and structure-activity relationships of alkene linked bis-galanthamine and galanthamine-galanthamine salts. Bioorg. Med. Chem. Lett. 10: 637-639
11. Hu, M.-L., Wu, L.-J., Hsiao, G., Yen, M.-H. (2002) Homodimeric tacrine congeners as acetylcholinesterase inhibitors. J. Med. Chem. 45: 2277-2282
12. Kapková, P., Stiefl, N., Sürig, U., Engels, E., Baumann, K., Holzgrabe, U. (2003) Synthesis, biological activity and docking studies of new acetylcholinesterase inhibitors of the bispyridinium type. Arch. Pharm. Pharm. Med. Chem. In press
13. Kryger, G., Silman, I., Sussman, J. L. (1998) Three-dimensional structure of a complex of E2020 with acetylcholinesterase from Torpedo californica. J. Physiol. Paris 92: 191-194
14. Millner, R. G. (1981) Simultaneous Statistical Inference. 2nd Edn, Springer-Verlag, New York, pp 143-157
15. Radić, Z., Pickering, A. N., Vellom, C. D., Camp, S., Taylor, P. (1993) Three distinct domains in the cholinesterase molecule confer selectivity for acetyl- and butyrylcholinesterase inhibitors. Biochemistry 32: 12074-12084
16. Shen, T., Tai, K., Henchman, R. H., McCammon, J. A. (2002) Molecular dynamics of acetylcholinesterase. Acc. Chem. Res. 35: 332-340